A Tennessee man is suing the makers of the blood thinner Xarelto alleging the companies filed to warn that the medication could cause serious and life-threatening bleeding events.
John Lovier claims that he suffered a gastrointestinal bleed in June 2016 after being treated with Xarelto, which not only caused him physical pain, but left him with medical, hospital and surgical expenses. He filed his lawsuit in the U.S. District Court for the Eastern District of Louisiana and is seeking compensation from Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals Inc., Johnson & Johnson, Bayer Healthcare LLC, Bayer Healthcare AG, and Bayer AG.
Lovier alleges the anticoagulant Xarelto was not properly researched and tested by its manufacturers before it was marketed to the public. He also said that the medication was approved without blood monitoring by medical professionals or any required adjustments to dosages that could have prevented serious bleeding events.
Xarelto was approved in July 2011, and is used to prevent strokes in patients with the common heart rhythm abnormality atrial fibrillation. It is also used to prevent and treat deep vein thrombosis and pulmonary embolism, and to prevent blood clots in patients who have recently undergone hip or knee replacement surgery. It is designed as an alternative to the long-used warfarin.
Blood thinners increase the risk for serious bleeding events including gastrointestinal bleeds and brain bleeds. But, it wasn’t until last month – six years after Xarelto’s approval – that the Food and Drug Administration (FDA) approved the first and only antidote to stop uncontrolled bleeding caused by Xarelto and a similar blood thinner, Eliquis.
Source: Louisiana Record